A M Tershakovec
Overview
Explore the profile of A M Tershakovec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toth P, Morrone D, Weintraub W, Hanson M, Lowe R, Lin J, et al.
Int J Clin Pract
. 2012 Jul;
66(8):800-812.
PMID: 22805272
Aims: The aim of this analysis was to assess the overall safety and tolerability profiles of various statins + ezetimibe vs. statin monotherapy and to explore tolerability in sub-populations grouped...
2.
Leiter L, Bays H, Conard S, Lin J, Hanson M, Shah A, et al.
Int J Clin Pract
. 2010 Oct;
64(13):1765-72.
PMID: 20946261
Background: Canadian and European treatment guidelines identify low-density lipoprotein cholesterol (LDL-C) as a primary treatment target for hypercholesterolaemia. Objectives: This post hoc analysis compared ezetimibe 10 mg (ezetimibe) added to...
3.
Fazio S, Guyton J, Lin J, Tomassini J, Shah A, Tershakovec A
Diabetes Obes Metab
. 2010 Oct;
12(11):983-93.
PMID: 20880345
Aims: To assess the efficacy and safety of ezetimibe/simvastatin (E/S) plus extended-release niacin (N) in hyperlipidaemic patients with diabetes mellitus (DM), metabolic syndrome (MetS) without DM (MetS/non-DM) or neither (non-DM/non-MetS)....
4.
Conard S, Bays H, Leiter L, Bird S, Lin J, Hanson M, et al.
Diabetes Obes Metab
. 2010 Feb;
12(3):210-8.
PMID: 20151997
Aim: Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) are both associated with increased risk for atherosclerotic coronary heart disease (CHD). Thus, it is useful to know the relative...
5.
Tomassini J, Mazzone T, Goldberg R, Guyton J, Weinstock R, Polis A, et al.
Diabetes Obes Metab
. 2009 Jun;
11(9):855-64.
PMID: 19508464
Aim: To evaluate the effects of the usual starting and next higher doses of ezetimibe/simvastatin and atorvastatin on the cholesterol content of lipoprotein subclasses in patients with type 2 diabetes...
6.
Bingham 3rd C, Bird S, Smugar S, Xu X, Tershakovec A
Osteoarthritis Cartilage
. 2008 Jun;
16(11):1289-93.
PMID: 18514551
Objectives: To determine the proportion of responders in two identical osteoarthritis (OA) trials using Outcome Measures in Arthritis Clinical Trials-Osteoarthritis Research Society International (OMERACT-OARSI) criteria and to assess the comparability...
7.
Oparil S, Abate N, Chen E, Creager M, Galet V, Jia G, et al.
Curr Med Res Opin
. 2008 Mar;
24(4):1101-14.
PMID: 18328120
Objectives: The objective of this study was to evaluate the effects of losartan +/- hydrochlorothiazide (HCTZ) versus placebo in obese patients with systolic and diastolic hypertension. Research Design And Methods:...
8.
Bingham 3rd C, Sebba A, Rubin B, Ruoff G, Kremer J, Bird S, et al.
Rheumatology (Oxford)
. 2006 Aug;
46(3):496-507.
PMID: 16936327
Objective: To compare the efficacy of etoricoxib 30 mg with the generally maximum recommended dose of celecoxib, 200 mg, in the treatment of osteoarthritis (OA) in two identically designed studies....
9.
Birbara C, Ruoff G, Sheldon E, Valenzuela C, Rodgers A, Petruschke R, et al.
Curr Med Res Opin
. 2006 Jan;
22(1):199-210.
PMID: 16393445
Objective: To compare the lower osteoarthritis (OA) dose of rofecoxib to the recommended dose of celecoxib in two identically designed studies. Methods: Patients with knee OA were randomized (2:2:1 ratio:...
10.
Lacey J, Tershakovec A, Foster G
Int J Obes Relat Metab Disord
. 2003 Mar;
27(4):419-27.
PMID: 12664074
Although acupuncture is being utilized to treat a variety of important health problems, its usefulness in obesity management has not yet been fully evaluated. The aim of this review paper...